LAFYX
Price
$17.95
Change
+$0.17 (+0.96%)
Updated
Apr 23 closing price
Net Assets
5.59B
RMFCX
Price
$53.01
Change
+$0.55 (+1.05%)
Updated
Apr 23 closing price
Net Assets
96.25B
Ad is loading...

LAFYX vs RMFCX

Header iconLAFYX vs RMFCX Comparison
Open Charts LAFYX vs RMFCXBanner chart's image
Lord Abbett Affiliated I
Price$17.95
Change+$0.17 (+0.96%)
VolumeN/A
Net Assets5.59B
American Funds American Mutual R3
Price$53.01
Change+$0.55 (+1.05%)
VolumeN/A
Net Assets96.25B
LAFYX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LAFYX vs. RMFCX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAFYX is a Buy and RMFCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 96.2B vs. LAFYX (5.59B). LAFYX pays higher dividends than RMFCX: LAFYX (1.86) vs RMFCX (1.34). LAFYX was incepted earlier than RMFCX: LAFYX (27 years) vs RMFCX (23 years). RMFCX (0.91) is less costly to investors than LAFYX (0.45). LAFYX is a more actively managed with annual turnover of: 57.00 vs. RMFCX (31.00). RMFCX has a lower initial minimum investment than LAFYX: RMFCX (250) vs LAFYX (1000000). RMFCX annual gain was more profitable for investors over the last year : 1.37 vs. LAFYX (-0.03). LAFYX return over 5 years is better than : 54.45 vs. RMFCX (50.63).
LAFYXRMFCXLAFYX / RMFCX
Total Expense Ratio0.450.9149%
Annual Report Gross Expense Ratio0.450.9149%
Fund Existence27 years23 years-
Gain YTD-4.712-3.599131%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets5.59B96.2B6%
Annual Yield % from dividends1.861.34138%
Returns for 1 year-0.031.37-2%
Returns for 3 years8.537.19119%
Returns for 5 years54.4550.63108%
Returns for 10 years23.1951.6445%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEAPX25.92N/A
N/A
Principal Glb Emerging Markets R3
HGHTX39.89N/A
N/A
Hartford Healthcare R5
PASIX10.54N/A
N/A
PACE Alternative Strategies A
FZANX39.11N/A
N/A
Fidelity Advisor New Insights Z
TQVIX16.60N/A
N/A
T. Rowe Price Integrated US LCV Eq I